2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1154543932 MD
Verify on CMS →

BRENT WISSE, MD

Endocrinology, Diabetes & Metabolism Physician in SEATTLE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
744
Medicare Part D claims · 87 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.0932/100
▲ 10 pts above national avg 83.1 · [object Object]

What the federal data shows

BRENT WISSE, MD reported a CMS MIPS final score of 93.0932/100 — above the 83.1 national average — and filed 744 Medicare Part D claims in 2023.

93.0932/100
MIPS score · +10 vs avg
744
Part D claims, 2023
58%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BRENT WISSE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

93 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BRENT WISSE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BRENT WISSE, MD?

High performer (top quartile)

NPI registry status

Active

Issued 05/02/2007

NPI 1154543932

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

744 72% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

93.0932/100 9.993200000000002% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Washington

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Washington providers

Washington providers

Endocrinology, Diabetes & Metabolism Physician share within Washington

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Washington

Medicare quality performance — MIPS

BRENT WISSE, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
93.0932/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 93.0932/100 vs national avg 83.1

0%100%National avg83%93.1%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 93.0932/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BRENT WISSE, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 325 9TH AVE, SEATTLE, WA, 98104, with a listed phone of (206) 731-3241. NPI 1154543932 was issued on 05/02/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WISSE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 744 prescription claims written by this provider, covering 87 Medicare beneficiaries and totaling roughly $246K in drug spend, split 42% brand-name and 58% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.0932/100 for the 2023 performance year (Quality 73.9573), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

325 9TH AVE
SEATTLE, WA 98104

Provider Details

NPI 1154543932
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 05/02/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.0932
Final Score
Avg: 83.1
73.9573
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where BRENT WISSE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

THE ASSOCIATION OF UNIVERSITY PHYSICIANS
SEATTLE, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to BRENT WISSE, MD. To verify BRENT WISSE, MD's current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

BRENT WISSE, MD — brand share 42.0%
Specialty average (est.)

42% brand-name claims vs 58% generic, on 744 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

744
Total Claims
$246K
Total Drug Cost
87
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,532
Total Day Supply
45,209
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$219K
Generic Drug Cost
$23K

Patient Demographics

Average Patient Age
67.9 years
Avg HCC Risk Score
1.51
Gender Split
40% female / 60% male
Age Distribution
<65: 23, 65-74: 42, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BRENT WISSE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
127
Hydrocortisone
97
Jardiance
Empagliflozin
28
Pioglitazone Hcl
25
Ozempic
Semaglutide
24
Cabergoline
21
Desmopressin Acetate
Desmopressin (Nonrefrigerated)
19
Farxiga
Dapagliflozin Propanediol
19
Metformin Hcl
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How BRENT WISSE, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

BRENT WISSE, MD's 744 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as WISSE.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BRENT WISSE, MD's specialty?
BRENT WISSE, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in SEATTLE, Washington. Credentials: MD.
How much does BRENT WISSE, MD prescribe under Medicare Part D?
In 2023, BRENT WISSE, MD wrote 744 Medicare Part D claims totaling $246K in drug costs for 87 beneficiaries.
What is BRENT WISSE, MD's Medicare quality score?
BRENT WISSE, MD has a CMS MIPS Final Score of 93.0932/100 (Quality: 73.9573). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BRENT WISSE, MD located?
BRENT WISSE, MD is located at 325 9TH AVE, SEATTLE, WA, 98104. Phone: (206) 731-3241.
What is BRENT WISSE, MD's NPI number?
BRENT WISSE, MD's National Provider Identifier (NPI) is 1154543932, issued on 05/02/2007.
Does BRENT WISSE, MD prescribe more brand-name or generic drugs?
BRENT WISSE, MD's prescribing is 42% brand-name and 58% generic drugs by claim count, with $219K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does BRENT WISSE, MD prescribe most often?
Based on 2023 Medicare Part D data, BRENT WISSE, MD's most frequently prescribed drugs include Levothyroxine Sodium, Hydrocortisone, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BRENT WISSE, MD accept Medicare?
BRENT WISSE, MD appears in CMS Medicare data with 744 Part D claims and 87 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BRENT WISSE, MD's credentials?
BRENT WISSE, MD's NPI is 1154543932 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology